Opportunity RFA-OD-09-008

The summary for the Opportunity RFA-OD-09-008 grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Opportunity RFA-OD-09-008: Purpose. This Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA), Public Law 111-5, solicits grant applications for a new initiative called Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Pilot Program (RC3). The purpose of this pilot program is to address the funding gap between promising research and development (R and D) and transitioning to the market -- often called the Valley of Death -- by contributing to the critical funding needed by applicants to pursue the next appropriate milestone(s) toward ultimate commercialization; i.e., to carry out later stage research activities necessary to that end. This program aims to accelerate the transition of research innovations and technologies toward the development of products or services that will improve human health, help advance the mission of NIH and its Institutes and Centers (ICs), and create significant value and economic stimulus. This program also aims to foster partnerships among a variety of research and development (R and D) collaborators working toward these aims. Mechanism of Support. This FOA will utilize the RC3 grant mechanism. Funds Available and Anticipated Number of Awards. Contingent upon the submission of a sufficient number of scientifically meritorious applications, NIH intends to commit at least $35 million in response to this FOA. We anticipate that at least 10 awards will be made in fiscal year 2010, pending the number and quality of applications and availability of funds. As a pilot, an evaluation will be necessary before any reissuance of this FOA; any reissuance is also predicated on funds availability. Applications received under this FOA may be given funding priority if the project is deemed to have high commercial potential to be developed into a product or service as indicated by the underserved need being addressed, the lack of alternative resources in the market and/or the applicants ability to secure funding or in-kind support from an independent third-party investor and/or strategic partner.
Federal Grant Title: Opportunity RFA-OD-09-008
Federal Agency Name: National Institutes of Health
Grant Categories: Health Recovery Act
Type of Opportunity: Other
Funding Opportunity Number: RFA-OD-09-008
Type of Funding: Grant
CFDA Numbers: 93.701
CFDA Descriptions: Trans-NIH Recovery Act Research Support
Current Application Deadline: Sep 01, 2009
Original Application Deadline: Sep 01, 2009
Posted Date: Jun 02, 2009
Creation Date: Jul 24, 2009
Archive Date: Oct 02, 2009
Total Program Funding:
Maximum Federal Grant Award: $1,000,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
For profit organizations other than small businesses - Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: This FOA encourages submissions by United-States for-profit enterprises/commercial organizations doing a majority of their business in the United States. Applications received under this FOA may be given funding priority if the applicant is associated with an enterprise/commercial organization that is of small size (e.g., 500 or fewer employees), and/or of limited resources, such as an early-stage company, and/or one positioned for receiving funding or in-kind support from a third-party investor and/or strategic partner. The applicant United States institution/organization must be located in the 50 states, territories and possessions of the U.S., Commonwealth of Puerto Rico, Trust Territory of the Pacific Islands, or District of Columbia. NIH encourages applications from all interested organizations/institutions, including those from Institutional Development Award (IDeA) states. Foreign organizations/institutions are not permitted as the applicant organization. If the application includes subcontractors, the applicant for-profit enterprise/commercial organization must be substantially involved in the R and D, with a leadership role in the project and defining the research agenda.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Stress Pathways in Alcohol Induced Organ Injury and Protection (R21)
Stress Pathways in Alcohol Induced Organ Injury and Protection (R01)
The Role of Cellular Organelles in Alcohol-Induced Tissue Injury (R01)
The Role of Cellular Organelles in Alcohol-Induced Tissue Injury (R21)
ARRA OS Recovery Act Limited Competition: Impact of Decision-Support Systems on the Dissem...
Recovery Act Limited Competition: NIH Challenge Grants in Health and Science Research (RC1...
Recovery Act Limited Competition: Core Facility Renovation, Repair, and Improvement (G20)
Administrative Supplements Providing Summer Research Experiences for Students and Science ...
More Grants from the National Institutes of Health
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com